Jane Brock, BM, BS, PhD

Dr. Jane Brock is an Assistant Professor of Pathology at Harvard Medical School and Chief of the Breast Pathology Division at Brigham and Women’s Hospital (BWH), Boston. She leads a high-volume breast pathology service of seven specialists. The breast pathology service provides clinical diagnostic services to BWH and Dana Farber Cancer Institute (DFCI), and research support to DFCI and BWH physicians involved in clinical trials. It trains and educates residents and fellows producing experts in breast pathology who can advance the field and promote the health of women with breast disease. The breast service sees over six thousand cases per year and this includes a private consultation service for pathologists, clinicians and patients nationally and internationally, providing diagnoses for the most challenging breast pathology cases. Dr. Brock is the Medical Director of the BWH Surgical Pathology Grossing Room and in addition to teaching surgical pathology residents and fellows, is involved in quality improvements, particularly in specimen tracking and handling.

Dr. Brock’s unique academic interests lie in global health and innovative methods of cancer diagnosis for use in low-resource settings. She oversees the BWH Pathology department’s support of Partners-In-Health Charity, budgeting for immunohistochemistry services and review of pathology cases for Haiti and Rwanda. She leads the ASCP-sponsored telepathology service in Rwanda and is active with the American Society of Clinical Pathology (ASCP) and C/CAN2025 in Myanmar, and provides breast telepathology diagnoses for Brigham Evergrande International Hospital (BEIH) in China. She has given national and international talks and organized educational workshops to pathologists, other physicians and non-physicians on a variety of subjects including breast pathology diagnosis, gross specimen evaluation, synoptic reporting, surgical specimen tissue handling, quality metrics in breast cancer pathology, laboratory quality management, and point-of-care cancer diagnostic technologies for use in low-resource settings.


Related Sessions

View full schedule